As the industry grows, consistency is quietly becoming one of the most important variables in consumer trust.
Read More
The Data Integrity Problem in Cannabis Retail: Why Product Consistency May Become the Industry’s Biggest Trust Challenge
Cannabis Without Context: Why Consumer Education Is Failing Faster Than Product Innovation
As cannabis becomes increasingly integrated into wellness culture, education can no longer function as a secondary consideration.
Read More
The Psychology of “Safe” Substances: How Legal Cannabis Is Reshaping Consumer Risk Perception
Many consumers now interpret legal cannabis as inherently low-risk simply because it exists within a regulated market.
Read More
From Pharmaceutical Logic to Lifestyle Branding: The Identity Shift Happening Inside the Cannabis Industry
Cannabis is no longer being positioned solely through the language of medicine, regulation, or symptom management.
Read More
Understanding the Importance of Informed Consumer Choices in Emerging Industries
As industries continue to expand and evolve, the ability to make informed choices becomes increasingly valuable.
Read More
How Public Awareness Shapes Safer Health and Wellness Decisions
Public awareness serves as the foundation that allows individuals to navigate this complexity with confidence.
Read More
The Medicinal Uses of Tetrahydrocannabinol (THC)
Daniel Fung of Watertown, CT explains that while marijuana is officially as a Schedule I substance, it's gained positive traction for its medical potential.
Read More
The Difference Between THC and CBD: What Consumers Need to Know
When it comes to vaping oils and other types of cannabis products, many people are often confused about or unaware of the differences between THC and CBD. These two cannabinoids offer different benefits for users, which is why it’s important to understand what each one has to offer when it comes to choosing the right product.
Daniel Fung of Watertown, CT explains below some of the key differences of both, exploring their effects on the body and what benefits each one offers. By understanding these differences, buyers can make an informed decision about which product is right for them.
Dosage
One of the first major differences between THC and CBD is the dosage required to attain the desired effects. While both cannabinoids can be found in many cannabis products like oils, edibles, and vapes, they are not always present in equal amounts. In fact, some products contain mostly THC while others contain mostly CBD.
While THC and CBD work in similar ways within the body, they have different effects depending on how much is consumed. For example, if someone consumes a high amount of THC, they may experience feelings of euphoria, relaxation, and even hallucinations. On the other hand, if someone consumes a high dose of CBD, they may experience reduced anxiety and stress.
Effects on Body
Dosage makes a significant difference. However, the way the body reacts is based on how individuals tolerate cannabinoid receptors in the body.
THC works by binding to CB1 receptors, which are found mostly in the brain and central nervous system. This is what leads to feelings of joy and relaxation. CBD, on the other hand, works by binding to CB2 receptors, which are found mostly in the immune system. This leads to reduced inflammation and pain, as well as reduced symptoms of anxiety and depression.
Medical Benefits
In addition to the different effects they have on the body, THC and CBD offer a variety of medical benefits. Both cannabinoids are known for their use in treating various conditions, such as chronic pain, inflammation, anxiety, depression, insomnia, and nausea.
THC is most commonly used to treat chronic pain and inflammation due to its ability to bind to CB1 receptors and reduce the activity of neurons that cause pain. As a result, it can be used to reduce symptoms such as headaches, muscle spasms, and arthritis pain.
CBD is most commonly used to treat anxiety, depression, insomnia, and nausea. Some studies have also shown that CBD may be useful in reducing the frequency and severity of seizures caused by epilepsy.
Legality
The legality of THC and CBD can also differ depending on the state in which they are being used. While both cannabinoids are considered to be legal in most states, some only allow the use of CBD due to its medical benefits.
Meanwhile, THC is generally not allowed or used for medical purposes in these states due to the “high” feeling associated with the use of cannabis.
Availability
Finally, the last major difference between the products is their availability. While both cannabinoids can be found in a variety of products, such as vapes, oils, and edibles, CBD is known to be more widely available than THC. This is because it has been shown to have many medical benefits that make it a desirable product for many.
The difference in availability is also caused by the legality issues, which make it safer and easier for companies to produce and market products containing CBD.
Final Thoughts
Overall, while both THC and CBD are known to have a variety of effects on the body and mind, they do differ in a number of ways, including their dosage requirements, the effects they have on the body, their medical benefits, and their legality. By understanding these differences, buyers can make a well-informed decision about which product is right for them and their needs.
Daniel Fung Reviews Supreme Court Justice’s Stance on Outdated Federal Marijuana Laws
For many years, the United States has had a complex and challenging relationship with marijuana. This relationship came to a head in 2005, when the Supreme Court passed a ruling that under the Commerce Clause of the US Constitution, Congress can criminalize the production and use of homegrown cannabis even if state laws allow it for medicinal purposes. However, earlier this month, highly conservative justice Clarence Thomas made a statement saying that due to the recent new federal policies regarding marijuana, federal laws against marijuana use may no longer make sense. Daniel Fung, Watertown, CT resident, and cannabis expert, believes very strongly in the federal decriminalization of marijuana and is excited to see this recent development. Below, Daniel Fung of Watertown, CT, will review Supreme Court Justice Clarence Thomas’s statement and hopefully highlight the significance of this statement.
In a statement on Monday, conservative justice Clarence Thomas responded to a recent court hearing regarding the appeal of a Colorado medicinal marijuana dispensary that was denied federal tax breaks. To this, Clarence Thomas wrote, “A prohibition on interstate use or cultivation of marijuana may no longer be necessary or proper to support the federal government’s piecemeal approach.”
Today, thirty-six out of fifty states allow the use of medical marijuana, with 18 also allowing its recreational use. However, federal tax law does not allow marijuana businesses to deduct their own business expenses, meaning businesses that may be struggling might still owe significant federal income tax.
Although the Department of Justice does not allow federal prosecutors to pursue marijuana businesses that follow state laws, the IRS continues to enforce its own penalties against marijuana farms and dispensaries. Clarence Thomas stated that “this willingness to look the other way on marijuana is more episodic than coherent.” Within his five-page statement, Clarence Thomas would go on to say, “Federal policies of the past 16 years have greatly undermined its reasoning,” he said. “The federal government’s current approach is a half-in, half-out regime that simultaneously tolerates and forbids local use of marijuana.” For his final point, Clarence Thomas stated that another consequence of federal prohibition is that many state-legal cannabis operations must operate cash-only due to restrictions on using federally backed financial institutions, and because of this, many marijuana facilities are a target to robbers and burglars.
Daniel Fung of Watertown CT Discusses Research Suggesting CBD May Help Treat COVID-19
In the non-peer-reviewed, pre-clinical study “In Search of Preventative Strategies: Novel Anti-Inflammatory High-CBD Cannabis Sativa Extracts Modulate ACE2 Expression in Covid-19 Gateway Tissues” Canadian scientists at the University of Lethbridge have discovered cannabis may be able to block droplets of the virus from infecting human cells. The tests were conducted in April, when scientists looked to see how a sample of sativa extracts containing high amounts of the cannabinoid CBD interacted with the ACE2 pathways the virus uses to enter the body.
Daniel Fung Watertown CT cannabis expert notes that the results indicate, through testing several cannabis plants, extracts high in CBD may be able to block the proteins that COVID-19 uses as the gateway into the body. This is a notable finding for researchers, as it has been considered that cannabis could reduce the entry points into the body by as much as 70 percent. The researchers have stressed that more studies are needed to fully research if cannabis can modulate the enzyme, but teams are hopeful that cannabis can be utilized to decrease disease susceptibility of some of the most vulnerable of our population. Daniel Fung of Watertown CT acknowledges that, while many have heard of the immensely important research going into finding a vaccine for COVID-19, one cannot discount the ways in which effective and safe treatment can help us going forward.
One important thing of note in the study’s findings was that not just any variety of cannabis will prove useful for treatment, as the study suggests that a mere handful of the over 800 types of sativa available have seemed helpful for medical application. All the strains that are under further research were high in CBD (known for its anti-inflammatory properties), but low in the cannabis high producing cannabinoid, THC.
While the potential health benefits of marijuana have been studied for quite some time, Daniel Fung of Watertown CT recognizes that the idea that it can be used to help people during the pandemic is a huge finding for both the healthcare and cannabis industry. With research such as the findings presented by this study and dispensaries being labeled as essential businesses in several states during the pandemic, Daniel Fung believes that recent developments could go a long way towards further legitimizing the industry. The CBD industry, for example, has begun to boom as of recently but has faced questioning from skeptics about its true helpfulness as an anti-inflammatory and potential pain reliever. The findings of the University of Lethbridge team may prove that there is scientific legitimacy in these claims, facilitating even more growth in the space.